Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

NCT01341782 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism
Hemodialysis

Interventions

DRUG: paricalcitol
DRUG: maxacalcitol
DRUG: paricalcitol placebo
DRUG: maxacalcitol placebo

Sponsor

AbbVie (prior sponsor, Abbott)